この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Smadar K.に依頼
Australia
Molecular biologist & cancer researcher with 10 years of training and expertise in translational cancer research.
プロフィール概要
専門分野
サービス
Writing
Technical Writing
Research
Market Research,
Meta-Research,
Feasibility Study,
Fact Checking,
Gap Analysis,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis
Product Development
Product Validation
職務経験
Senior Research Officer
Children's Cancer Research Unit, The Children's Hospital at Westmead
7月 2021 - 現在
Research Officer
Children's Cancer Research Unit
7月 2017 - 現在 ![]()
Senior Research Assistant
Sheba Medical Center
1月 2012 - 8月 2016 ![]()
学歴
PhD in Biology (Biology)
Technion Israel Institute of Technology Faculty of Biology
10月 2005 - 7月 2011 ![]()
BA in Molecular Biochemistry (Chemistry)
Technion Israel Institute of Technology
10月 2002 - 10月 2005 ![]()
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Smadar Kahana-Edwin, Lucy E. Cain, Geoffrey McCowage, Artur Darmanian, Dale Wright, Anna Mullins, Federica Saletta, Jonathan Karpelowsky (2021). Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and ALK Genotyping via Cell-Free Circulating Tumor DNA Profiling . Cancers.
Smadar Kahana-Edwin, Lucy E. Cain, Geoffrey McCowage, Artur Darmanian, Dale Wright, Anna Mullins, Federica Saletta, Jonathan Karpelowsky (2021). Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and <i>ALK</i> Genotyping via Cell-Free Circulating Tumor DNA Profiling . Cancers.
Smadar Kahana‐Edwin, Geoffrey McCowage, Lucy Cain, Federica Saletta, Aysen Yuksel, Nicole Graf, Jonathan Karpelowsky(2020). Exploration of CTNNB1 ctDNA as a putative biomarker for hepatoblastoma . Pediatric Blood & Cancer. 67. (11). Wiley
(2020). Exploration of CTNNB1 ctDNA as a putative biomarker for hepatoblastoma . Pediatric Blood & Cancer.
(2020). TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients . Cancer Immunology, Immunotherapy.
(2020). ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis. Breast Cancer Research.
Dadiani M, Bossel Ben-Moshe N, Paluch-Shimon S, Perry G, Balint N, Marin I, Pavlovski A, Morzaev D, Kahana-Edwin S, Yosepovich A, et al.(2016). Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer . Clinical cancer research : an official journal of the American Association for Cancer Research.
Kahana-Edwin S, Stark M, Kassir Y(2013). Multiple MAPK cascades regulate the transcription of IME1, the master transcriptional activator of meiosis in Saccharomyces cerevisiae . PloS one.
Kahana S, Pnueli L, Kainth P, Sassi HE, Andrews B, Kassir Y(2010). Functional dissection of IME1 transcription using quantitative promoter-reporter screening . Genetics.